http://hdl.handle.net/10222/15762 Thu, 23 May 2013 21:04:32 GMT 2013-05-23T21:04:32Z http://hdl.handle.net/10222/21907 Promises and perils of cognitive performance tools: A dialogue Viirre, Erik; Baylis, Françoise; Downie, Jocelyn Cognitive performance tools are evolving and their application is expanding rapidly. Although these tools promise significant advantages, they also raise a number of significant ethical and social concerns. This paper first provides an overview of various cognitive performance tools. Subsequently, there is a dialogue between Viirre on the one hand and Baylis and Downie on the other. Together, they explore the promises and perils of cognitive performance tools available now, or in the near future (perhaps within the next ten to twenty years). The authors conclude there are potential benefits with the development and use of cognitive performance tools. Care must be taken, however, with respect to the ways in which such tools may not serve the interests of individuals and communities. Mon, 01 Jan 2007 00:00:00 GMT http://hdl.handle.net/10222/21907 2007-01-01T00:00:00Z http://hdl.handle.net/10222/15973 Confusion worse confounded. British Medical Journal [Rapid Response: Withdrawal of clinical trials policy by Canadian research institute is a “lost opportunity for increased transparency” by Ann Silversides. British Medical Journal 2011;342:d2570]. Baylis, Françoise; Downie, Jocelyn Rapid response to "Withdrawal of clinical trials policy by Canadian research institute is a 'lost opportunity for increased transparency'" by Ann Silversides. Wed, 04 May 2011 00:00:00 GMT http://hdl.handle.net/10222/15973 2011-05-04T00:00:00Z http://hdl.handle.net/10222/15971 Access to health care for women. [Letter to the Editor] Baylis, Françoise; Nelson, Hilde Lindemann Letter to the editor Wed, 01 Jan 1997 00:00:00 GMT http://hdl.handle.net/10222/15971 1997-01-01T00:00:00Z http://hdl.handle.net/10222/15969 Chimera Research and Stem Cell Therapies for Human Neurodegenerative Disorders Baylis, Françoise; Fenton, Andrew In April 2005, the U.S. National Academy of Sciences (NAS) published its Guidelines for Human Embryonic Stem Cell Research. These voluntary guidelines are among the most permissive in the world—in a country that prohibits federal funding of research to derive human embryonic stem (hES) cells (cells that can self-renew or differentiate into most cells in the human body). One of the few research prohibitions in the NAS guidelines concerns the creation of certain kinds of human–nonhuman chimeras. A chimera is an organism with a mixture of cells from two different organisms, from the same or different species. Figure 1 provides a useful overview of different types of chimeras. Mon, 01 Jan 2007 00:00:00 GMT http://hdl.handle.net/10222/15969 2007-01-01T00:00:00Z